Systemic inhibition of PTPN22 augments anticancer immunity is a research paper published in Journal of Clinical Investigation (2021). On theSindex it has a DataRank of 1.3. It has been cited 55 times, with 47 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.604
From this paper's citation signal
Citation Network Contribution
0.695
From 36 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 47 citers.
National Cancer Institute
Grant: P50 CA221707
American Association for Cancer Research
Grant: 132178
American Society of Clinical Oncology
Grant: 131809
National Cancer Institute
Grant: T32 CA009071
National Cancer Institute
Grant: RO1 CA207288
U.S. National Library of Medicine
Grant: R01 LM010685
MacMillan Foundation
Grant: Pathway to Independence
NCI NIH HHS
Grant: R50 CA243627
NCI NIH HHS
Grant: P50 CA062924
NCI NIH HHS
Grant: R01 CA194024
NCATS NIH HHS
Grant: UL1 TR000445
NCI NIH HHS
Grant: P50 CA098131
NCI NIH HHS
Grant: R01 CA214494
NCI NIH HHS
Grant: P01 CA247886
NCI NIH HHS
Grant: P50 CA221707
NCRR NIH HHS
Grant: S10 RR025141
NCRR NIH HHS
Grant: UL1 RR024975
NCI NIH HHS
Grant: P30 CA068485
NCI NIH HHS
Grant: R01 CA207288
NCI NIH HHS
Grant: T32 CA009071
NCI NIH HHS
Grant: R01 CA197296
NCATS NIH HHS
Grant: UL1 TR002243
National Institutes of Health
Grant: 5UL1TR002243-05
Vanderbilt Institute for Clinical and Translational Research (VICTR)
National Institutes of Health
Grant: 3UL1RR024975-03S4
The Vanderbilt Institute for Clinical and Translational Research (VICTR) UL1
National Institutes of Health
Grant: 1R01LM010685-01A1
From GWAS to PheWAS: Scanning the EMR phenome for gene-disease associations
National Institutes of Health
Grant: 5R01CA207288-02
Development of SHP2 inhibitors for targeted anti-cancer therapy
National Institutes of Health
Grant: 1S10RR025141-01
Automated Storage and Retrieval of Biological Systems
National Institutes of Health
Grant: 6UL1TR000445-11
The Vanderbilt Institute for Clinical and Translational Research (VICTR)
FWCI
2.52
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals